McGrath Rentcorp (MGRC) Reaches $49.66 52-Week High; Diplomat Pharmacy Has 1.44 Sentiment

January 14, 2018 - By Winifred Garcia

The stock of McGrath Rentcorp (NASDAQ:MGRC) hit a new 52-week high and has $53.63 target or 8.00% above today’s $49.66 share price. The 8 months bullish chart indicates low risk for the $1.19 billion company. The 1-year high was reported on Jan, 14 by Barchart.com. If the $53.63 price target is reached, the company will be worth $95.44M more. The stock increased 1.45% or $0.71 during the last trading session, reaching $49.66. About 78,103 shares traded. McGrath Rentcorp (NASDAQ:MGRC) has risen 25.54% since January 14, 2017 and is uptrending. It has outperformed by 8.84% the S&P500.

Diplomat Pharmacy, Inc. operates as an independent specialty pharmacy in the United States. The company has market cap of $1.89 billion. The firm stocks, dispenses, and distributes prescriptions for various biotechnology and specialty pharmaceutical manufacturers. It has a 221.62 P/E ratio. It also provides specialty infusion pharmacy, patient care coordination, clinical, compliance and persistency program, patient financial assistance, specialty pharmacy training/consulting, benefits investigation, prior authorization, risk evaluation and medication strategy, retail specialty, and hub services, as well as clinical and administrative support services to hospitals and health systems.

Investors sentiment decreased to 1.17 in Q3 2017. Its down 0.11, from 1.28 in 2017Q2. It is negative, as 10 investors sold McGrath Rentcorp shares while 37 reduced holdings. 22 funds opened positions while 33 raised stakes. 19.48 million shares or 0.23% more from 19.43 million shares in 2017Q2 were reported. Northern Tru invested 0.01% of its portfolio in McGrath Rentcorp (NASDAQ:MGRC). Aqr Cap Mngmt Ltd Liability invested in 0% or 88,408 shares. Citadel Advsrs Limited Liability Co holds 0% or 8,314 shares. Employees Retirement Systems Of Ohio reported 0% of its portfolio in McGrath Rentcorp (NASDAQ:MGRC). Mondrian Investment Prns Limited invested 0.08% in McGrath Rentcorp (NASDAQ:MGRC). Ameritas Invest has 2,018 shares for 0% of their portfolio. Sg Cap Management holds 0.21% or 44,212 shares. Amer owns 15,711 shares. D E Shaw And Com Inc, a New York-based fund reported 26,555 shares. Legal & General Plc invested 0% of its portfolio in McGrath Rentcorp (NASDAQ:MGRC). Bw Gestao De Investimentos Ltda invested 0.17% in McGrath Rentcorp (NASDAQ:MGRC). Manufacturers Life Ins Comm The stated it has 17,780 shares. Alliancebernstein Limited Partnership has 33,572 shares for 0% of their portfolio. Invesco Limited has 31,675 shares. 1.58M are held by Franklin Inc.

Since August 4, 2017, it had 0 insider purchases, and 8 selling transactions for $954,261 activity. $78,176 worth of stock was sold by PRATT KEITH E on Thursday, September 7. The insider Dashner Kay sold $100,000. 1,043 McGrath Rentcorp (NASDAQ:MGRC) shares with value of $41,535 were sold by Whitney David M. VAN TREASE KRISTINA had sold 3,400 shares worth $134,684 on Thursday, September 7. Skenesky John P sold $290,835 worth of stock or 7,561 shares.

Among 3 analysts covering McGrath RentCorp (NASDAQ:MGRC), 1 have Buy rating, 0 Sell and 2 Hold. Therefore 33% are positive. McGrath RentCorp had 4 analyst reports since November 4, 2015 according to SRatingsIntel. Sidoti upgraded the stock to “Buy” rating in Friday, January 8 report. The firm earned “Buy” rating on Wednesday, September 14 by Sidoti. The rating was downgraded by KeyBanc Capital Markets to “Sector Weight” on Wednesday, November 4. The firm has “Hold” rating by Oppenheimer given on Thursday, August 3.

McGrath RentCorp, a business to business rental company, rents and sells relocatable modular buildings, electronic test equipment, and liquid and solid containment tanks and boxes in the United States and internationally. The company has market cap of $1.19 billion. It operates through four divisions: Mobile Modular, TRS-RenTelco, Adler Tanks, and Enviroplex. It has a 26 P/E ratio. The Mobile Modular segment rents and sells modular buildings designed for use as classrooms, temporary offices adjacent to existing facilities, sales offices, construction field offices, restroom buildings, health care clinics, child care facilities, office space, and various other purposes; and portable storage containers.

Analysts await McGrath Rentcorp (NASDAQ:MGRC) to report earnings on February, 27. They expect $0.55 EPS, up 37.50% or $0.15 from last year’s $0.4 per share. MGRC’s profit will be $13.21M for 22.57 P/E if the $0.55 EPS becomes a reality. After $0.69 actual EPS reported by McGrath Rentcorp for the previous quarter, Wall Street now forecasts -20.29% negative EPS growth.

Ratings analysis reveals 0 of Diplomat Pharmacy’s analysts are positive. Out of 2 Wall Street analysts rating Diplomat Pharmacy, 0 give it “Buy”, 1 “Sell” rating, while 1 recommend “Hold”. DPLO was included in 2 notes of analysts from November 3, 2016. The rating was downgraded by Credit Suisse on Wednesday, November 23 to “Underperform”. Mizuho maintained the stock with “Neutral” rating in Thursday, November 3 report.

Analysts await Diplomat Pharmacy, Inc. (NYSE:DPLO) to report earnings on February, 27. They expect $0.16 earnings per share, up 100.00% or $0.08 from last year’s $0.08 per share. DPLO’s profit will be $11.67M for 40.52 P/E if the $0.16 EPS becomes a reality. After $0.25 actual earnings per share reported by Diplomat Pharmacy, Inc. for the previous quarter, Wall Street now forecasts -36.00% negative EPS growth.

The stock increased 3.60% or $0.9 during the last trading session, reaching $25.93. About 1.09 million shares traded or 44.50% up from the average. Diplomat Pharmacy, Inc. (DPLO) has declined 40.48% since January 14, 2017 and is downtrending. It has underperformed by 57.18% the S&P500.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>